RADIOLOGICAL CORRELATES OF COGNITIVE DYSFUNCTION IN ALS
ALS 认知功能障碍的放射学相关性
基本信息
- 批准号:7952113
- 负责人:
- 金额:$ 0.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisBrainBrain scanClinicalClinical ResearchCognitiveComputer Retrieval of Information on Scientific Projects DatabaseDataDementiaDiseaseFunctional Magnetic Resonance ImagingFundingFutureGoalsGrantHealthImpaired cognitionInstitutionLettersMRI ScansMagnetic Resonance ImagingMeasuresMemoryMotor NeuronsNeurologicPatientsPatternProceduresResearchResearch PersonnelResourcesSeverity of illnessSourceSpousesStructureTechniquesTestingThinkingTimeUnited States National Institutes of Healthcognitive changecognitive functionneurocognitive testresearch study
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease has been viewed as a disease primarily affecting motor neurons. We now know that cognitive dysfunction, with abnormalities in thinking and memory, occur in some patients suggesting that ALS may not be limited to motor neurons. Several techniques in brain scanning, particularly MRI, allow for examination of changes in the structure and function of the brain. It is not known whether ALS patients with normal cognitive function differ from those with cognitive dysfunction with respect to structural and/or functional abnormalities on brain MRI.
The goals of this study are to examine cognitive function in ALS in parallel with findings on MRI over 12 months to assess changes over time and to correlate them with other commonly used clinical measures of disease severity, such as ALS function and ALS Health State.
Hypotheses
Hypothesis #1: MRI abnormalities will be greater in ALS patients with cognitive dysfunction than those without, after controlling for disease severity.
Hypothesis #2: ALS patients with cognitive dysfunction will demonstrate brain activation patterns on functional MRI (fMRI) that are different from those without cognitive dysfunction, after controlling for disease severity.
Specific Aims
To test these hypotheses we propose to undertake the following experiments:
1.) To undertake formal neurocognitive testing and MRI scans in ALS patients and healthy controls for comparison between groups and correlation of cognitive data with MRI data in ALS patients.
2.) To perform serial MRI studies and fMRI in ALS patients at 4-month intervals to determine changes over time and permit correlations with cognitive abnormalities and clinical measures of disease severity.
Procedures
ALS patients and healthy normals (spouses or regulars) will undergo cognitive testing, MRI brain scans, and specialized cognitive testing while in the MRI machine. This will permit an analysis of the structure of the brain, and how it is activated during specialized testing when subjects perform a task of enumerating words starting with specific letters. Normals will be tested once, and ALS patients will be tested every 3-months for a year. Statistical tests will permit comparisons of differences between ALS patients and normals.
Significance
These studies will not only enhance our understanding of the cognitive changes in ALS and its relation to other neurological illnesses associated with dementia, but also provide preliminary data for an in-depth examination of cognitive dysfunction and approaches to its possible treatment in the future.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUP TANDAN其他文献
RUP TANDAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUP TANDAN', 18)}}的其他基金
CLINICAL TRIAL: THYMECTOMY IN NON-THYMOMATOUS MG PTS RECEIVING PREDINISONE
临床试验:接受泼尼松治疗的非胸腺瘤 MG PTS 中的胸腺切除术
- 批准号:
8166969 - 财政年份:2010
- 资助金额:
$ 0.19万 - 项目类别:
CLINICAL TRIAL: THYMECTOMY IN NON-THYMOMATOUS MG PTS RECEIVING PREDINISONE
临床试验:接受泼尼松治疗的非胸腺瘤 MG PTS 中的胸腺切除术
- 批准号:
7952106 - 财政年份:2009
- 资助金额:
$ 0.19万 - 项目类别:
CLINICAL TRIAL: PILOT TRIAL OF RITUXIMAB IN REFRACTORY MYASTHENIA GRAVIS
临床试验:利妥昔单抗治疗难治性重症肌无力的试点试验
- 批准号:
7952100 - 财政年份:2009
- 资助金额:
$ 0.19万 - 项目类别:
CLINICAL TRIAL: EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV
临床试验:通过营养和 NIPPV 早期治疗 ALS
- 批准号:
7952103 - 财政年份:2009
- 资助金额:
$ 0.19万 - 项目类别:
TRIAL OF MINOCYCLINE IN 400 SUBJECTS WITH ALS
在 400 名 ALS 受试者中进行米诺环素试验
- 批准号:
7605799 - 财政年份:2007
- 资助金额:
$ 0.19万 - 项目类别:
PILOT TRIAL OF RITUXIMAB IN REFRACTORY MYASTHENIA GRAVIS
利妥昔单抗治疗难治性重症肌无力的试点试验
- 批准号:
7605796 - 财政年份:2007
- 资助金额:
$ 0.19万 - 项目类别:
CLINICAL TRIAL OF HIGH DOSE COQ10 IN ALS
高剂量 COQ10 治疗 ALS 的临床试验
- 批准号:
7605806 - 财政年份:2007
- 资助金额:
$ 0.19万 - 项目类别:
EFFECT OF THYMECTOMY IN NON-THYMOMATOUS MG PATIENTS ON PREDNISONE
胸腺切除术对非胸腺瘤重症肌无力患者的影响
- 批准号:
7605820 - 财政年份:2007
- 资助金额:
$ 0.19万 - 项目类别:
EARLY TREATMENT OF ALS WITH NUTRITION AND NIPPV
ALS 的早期营养治疗和 NIPPV 治疗
- 批准号:
7605807 - 财政年份:2007
- 资助金额:
$ 0.19万 - 项目类别:
相似海外基金
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 0.19万 - 项目类别:
Analysis of gut-brain axis disorder caused by amyloid from E. coli using amyotrophic lateral sclerosis fly model
利用肌萎缩侧索硬化症果蝇模型分析大肠杆菌淀粉样蛋白引起的肠脑轴紊乱
- 批准号:
22K15732 - 财政年份:2022
- 资助金额:
$ 0.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Wearable Brain-Computer Interface for Treating Amyotrophic Lateral Sclerosis (ALS) With A Neural Replacement Strategy
可穿戴脑机接口通过神经替代策略治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
2741039 - 财政年份:2022
- 资助金额:
$ 0.19万 - 项目类别:
Studentship
The gut-brain axis in a mouse model of amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD)
肌萎缩侧索硬化症-额颞叶痴呆 (ALS-FTD) 小鼠模型的肠脑轴
- 批准号:
428939 - 财政年份:2019
- 资助金额:
$ 0.19万 - 项目类别:
Studentship Programs
The mechanism linking traumatic brain injury to amyotrophic lateral sclerosis
创伤性脑损伤与肌萎缩侧索硬化症的联系机制
- 批准号:
8526220 - 财政年份:2012
- 资助金额:
$ 0.19万 - 项目类别:
Robust quantitative functional Magnetic Resonance Imaging (fMRI) of altered brain activity to investigate the association of Traumatic Brain Injuries (TBI) with Amyotrophic Lateral Sclerosis (ALS)
对改变的大脑活动进行稳健的定量功能磁共振成像 (fMRI),以研究创伤性脑损伤 (TBI) 与肌萎缩侧索硬化症 (ALS) 的关联
- 批准号:
258028 - 财政年份:2012
- 资助金额:
$ 0.19万 - 项目类别:
Fellowship Programs
The mechanism linking traumatic brain injury to amyotrophic lateral sclerosis
创伤性脑损伤与肌萎缩侧索硬化症的联系机制
- 批准号:
8397272 - 财政年份:2012
- 资助金额:
$ 0.19万 - 项目类别:
Brain Metabolic Imaging in Amyotrophic Lateral Sclerosis
肌萎缩侧索硬化症的脑代谢成像
- 批准号:
7590644 - 财政年份:2008
- 资助金额:
$ 0.19万 - 项目类别:
Brain Metabolic Imaging in Amyotrophic Lateral Sclerosis
肌萎缩侧索硬化症的脑代谢成像
- 批准号:
7692899 - 财政年份:2008
- 资助金额:
$ 0.19万 - 项目类别:
Brain Metabolic Imaging in Amyotrophic Lateral Sclerosis
肌萎缩侧索硬化症的脑代谢成像
- 批准号:
7891265 - 财政年份:2008
- 资助金额:
$ 0.19万 - 项目类别: